Protective Effect of Qiliqiangxin against Doxorubicin-Induced Cardiomyopathy by Suppressing Excessive Autophagy and Apoptosis

BACKGROUND: Doxorubicin (DOX) is one of the most potent and widely prescribed antitumor agents; however, its clinical use is limited by cardiac side effects. In this study, we aimed to clarify the protective effects of Qiliqiangxin (QL), a traditional Chinese medicine formulation, on DOX-induced car...

Descripción completa

Detalles Bibliográficos
Autores principales: Qin, Yating, Lv, Chao, Zhang, Xinxin, Ruan, Weibin, Xu, Xiangyu, Chen, Chen, Wan, Xiaoning, Ji, Xinyun, Zhou, Juan, Lu, Li, Guo, Xiaomei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8813302/
https://www.ncbi.nlm.nih.gov/pubmed/35169398
http://dx.doi.org/10.1155/2022/9926635

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8813302/
https://www.ncbi.nlm.nih.gov/pubmed/35169398
http://dx.doi.org/10.1155/2022/9926635

Ejemplares similares